Form 4: Arteris Inc. Director Saiyed Atiq Raza Sells Shares Under 10b5-1 Trading Plan

Director Saiyed Atiq Raza sold 3,025 shares of Arteris, Inc. common stock at an average price of $10.1553 on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On January 2, 2025, Saiyed Atiq Raza, a director of Arteris, Inc., sold 3,025 shares of common stock.
• The sale was executed at a weighted average price of $10.1553 per share, with individual transactions ranging from $10.00 to $10.24.
• The transaction was conducted under a 10b5-1 trading plan adopted on June 6, 2024.
• Following the transaction, Raza directly owns 19,287 shares and indirectly owns 687,096 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by a company director under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales by company insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices, avoiding accusations of trading on inside information.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates